{"id":893353,"date":[{"year":1992,"month":12,"day":27}],"page":"3","source":"本报","region":"","masthead":"科教文卫新闻","special_issue":"","column":"","genre":"","count":"196","ytitle":"","mtitle":"类风关患者欣获良药","ftitle":"","authors":["王琳"],"text":[{"type":"paragraph","text":"本报讯　(记者王琳)癌症、类风湿关节炎病患者不久将可用上生物高技术良药——γ干扰索。上海克隆生物高技术有限公司建建立起我国第一条、世界上第三个专门生产丫干扰素的生产线，目前正在进行临床试验，不日将可投入批量生产。这是一个对病毒性疾病、癌症和类风湿关节炎等有较好疗效的药物。该项目列入国家“八五”攻关的重点资助项目，它的投入生产一年后就可取得上千万元的经济效益。"}]}